bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG [Pylera]
RxNorm concept 1294620, branded drug component (sbdc).
- RxCUI
- 1294620
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294620 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG [Pylera]
Related concepts
- bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] (SBD, constitutes)
- Pylera (BN, has ingredient)
- metronidazole 125 MG (SCDC, tradename of)
- bismuth subcitrate 140 MG (SCDC, tradename of)
- tetracycline hydrochloride 125 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1294620 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294620 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1294620. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.